An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
Frank J Chaloupka, Kenneth E Warner, Daron Acemoğlu, Jonathan Gruber, Fritz Laux, Wendy Max, Joseph Newhouse, Thomas Schelling, Jody Sindelar
Tobacco Control Mar 2015, 24 (2) 112-119; DOI: 10.1136/tobaccocontrol-2014-052022